Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
46,063,476
-
Shares change
-
+2,123,901
-
Total reported value, excl. options
-
$823,150,946
-
Value change
-
+$42,521,553
-
Put/Call ratio
-
176%
-
Number of buys
-
72
-
Number of sells
-
-78
-
Price
-
$17.87
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q1 2021
182 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q1 2021.
AERIE PHARMACEUTICALS INC - COM (AERI) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,063,476 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (4,250,754 shares), BlackRock Inc. (3,563,969 shares), BANK OF AMERICA CORP /DE/ (2,660,099 shares), Woodline Partners LP (2,157,039 shares), PFM Health Sciences, LP (2,067,684 shares), LOOMIS SAYLES & CO L P (1,910,100 shares), MORGAN STANLEY (1,743,481 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,637,872 shares), AMERIPRISE FINANCIAL INC (1,591,132 shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1,411,454 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.